179 related articles for article (PubMed ID: 31853757)
1. Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis.
Chen L; Ou Z; Wang R; Zhang M; He W; Zhang J; Zu X; Yi L; Xu R; Jiang S; Qi L; Wang L
Ann Surg Oncol; 2020 Apr; 27(4):1297-1303. PubMed ID: 31853757
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
[TBL] [Abstract][Full Text] [Related]
4. Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma: A protocol for systematic review and meta analysis.
Li K; Xie W; Gao L; Huang G; Zhou J; Mei B; Chen J
Medicine (Baltimore); 2020 May; 99(18):e20184. PubMed ID: 32358407
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract][Full Text] [Related]
6. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.
Martini A; Falagario UG; Waingankar N; Daza J; Treacy PJ; Necchi A; Galsky MD; Sfakianos JP
Urol Oncol; 2020 Aug; 38(8):684.e9-684.e15. PubMed ID: 32284255
[TBL] [Abstract][Full Text] [Related]
8. Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Arita Y; Akita H; Jinzaki M; Kikuchi E; Oya M
Urol Oncol; 2022 Mar; 40(3):105.e19-105.e26. PubMed ID: 34454822
[TBL] [Abstract][Full Text] [Related]
9. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
[TBL] [Abstract][Full Text] [Related]
10. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
12. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.
Fujita K; Taneishi K; Inamoto T; Ishizuya Y; Takada S; Tsujihata M; Tanigawa G; Minato N; Nakazawa S; Takada T; Iwanishi T; Uemura M; Okuno Y; Azuma H; Norio N
BMC Urol; 2017 Dec; 17(1):110. PubMed ID: 29195499
[TBL] [Abstract][Full Text] [Related]
14. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
Hinata N; Hussein AA; George S; Trump DL; Levine EG; Omar K; Dasgupta P; Khan MS; Hosseini A; Wiklund P; Guru KA
BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481
[TBL] [Abstract][Full Text] [Related]
15. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study.
Tae JH; Ha MS; Chi BH; Chang IH; Kim TH; Myung SC; Nguyen TT; Kim M; Lee KE; Kim Y; Woo HK; Kyoung DS; Kim H; Choi SY
BMC Urol; 2022 Nov; 22(1):175. PubMed ID: 36352437
[TBL] [Abstract][Full Text] [Related]
17. Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
Birtle AJ; Jones R; Chester J; Lewis R; Biscombe K; Johnson M; Blacker A; Bryan RT; Catto JWF; Choudhury A; Das P; Jagdev S; Powles T; Wagstaff J; Cheung KC; Cafferty F; Hall E
J Clin Oncol; 2024 May; 42(13):1466-1471. PubMed ID: 38350047
[No Abstract] [Full Text] [Related]
18. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
[TBL] [Abstract][Full Text] [Related]
19. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.
Leow JJ; Martin-Doyle W; Fay AP; Choueiri TK; Chang SL; Bellmunt J
Eur Urol; 2014 Sep; 66(3):529-41. PubMed ID: 24680361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]